Fig. 3From: Economic consequences of migraine in Sweden and implications for the cost-effectiveness of onabotulinumtoxinA (Botox) for chronic migraine in Sweden and NorwayAnnual direct and indirect costs by number of headache days. Key: HA, headacheBack to article page